Overview of the ASRM Embryo Transfer Simulator Program and Findings from the ASRM Embryo Transfer Certificate Course
Tuesday 4th May, 2021. 3PM EST/ 8PM GMT / 9PM CET
DR. RICHARD H. REINDOLLAR
Richard H. Reindollar M.D. completed his tenure as the CEO/Executive Director of the American Society for Reproductive Medicine, December 31, 2020. He is Professor Emeritus of Obstetrics and Gynecology at Geisel School of Medicine at Dartmouth where he was Professor and Chair from 2005-2014. He previously served as Director of the Division of Reproductive Endocrinology and Infertility at Beth Israel Deaconess Medical Center, Harvard Medical School and New England Medical Center, Tufts Medical School. He is a past president of the Society for Reproductive Endocrinology and Infertility, the North American Society for Pediatric and Adolescent Gynecology, the New England Fertility Society, and the American Society for Reproductive Medicine from the conclusion of the 2013 ASRM Annual Meeting until he became the Society’s Executive Director. Dr. Reindollar has been a member of the Board of Directors of the American Society for Reproductive Medicine and a Board Delegate for the American Board of Obstetrics and Gynecology. He is board certified in Obstetrics and Gynecology, Reproductive Endocrinology and Infertility, and Medical Genetics. Dr. Reindollar was the principal investigator of two large NIH-funded infertility clinical trials, the FASTT and FORT-T trials.
KEITH A. RAY
Keith has been with the American Society for Reproductive Medicine (ASRM) for 13 years and is currently the Director of Special Projects & Corporate Relations. Much of his work at ASRM has involved various initiatives in simulation for Reproductive Surgery and Embryo Transfer, serving as the ASRM representative to the Council of Medical Specialty Societies Simulation Workgroup. He has served as co-director of the ASRM Embryo Transfer Program since project inception (2015), spanning both the development and program implementation phases. He has developed programs for deployment of Embryo Transfer simulation training to REI fellows, experienced practitioners, and IVF teams in the U.S. and globally.